Vice President, Development, Cell Therapy R&D
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Måløv
Vice President, Development, Cell Therapy R&DAre you an experienced and driven leader with a diverse background in global drug development? Do you thrive in collaborative environments and have a passion for driving innovative drug development strategies? If so, we have an exciting opportunity for you to join our Cell Therapy R&D team at Novo Nordisk. Read on and apply today for a life-changing career.The Department
In Cell Therapy R&D, our mission is to improve the lives of patients suffering from serious chronic diseases through innovative stem cell-based therapies. We want to be an industry leader in this rapidly developing area, which has the potential to address unmet medical needs and even cure serious chronic diseases. As a dedicated Transformational Research Unit (TRU) since late 2018, we have a high level of independence, agility and flexibility. This means we can combine the speed and agility of a small biotech with the capabilities of a major pharma company. We cover the full pharmaceutical value chain, from research to commercial, including a GMP manufacturing site in Fremont, working in close collaboration with leading international scientists and colleagues across Novo Nordisk. Novo Nordisk has been active in stem cell research for over 20 years in type 1 diabetes. Our portfolio has since expanded to many disease areas and indications, all working towards maturing and expanding our platform and capabilities.The Cell Therapy Development area is part of Cell Therapy R&D and encompasses an organization of approximately 22 professionals spread across several locations and time zones. Located at our Målov site in Denmark, the team collaborates closely with the larger Novo Nordisk Development organization, including the newly formed US-based “East Coast Hub” and our commercial partners in Rare Disease. The department is known for its collaborative and innovative approach to drug development, and we are committed to making a difference in the lives of patients.
The Position
Reporting to the Corporate Vice President for Cell Therapy R&D (CTRD), the new Vice President (VP) for Development will be a critical part of the CTRD leadership team, accountable for several functions involved in late-stage research and early to mid-stage clinical development of stem cell-based therapies. The new VP will have accountability for securing high quality, comprehensive drug development strategies for our cell therapy projects, covering all critical aspects incl. non-clinical, clinical development and maintaining strong collaborative efforts with internal and external partners.
As the Vice President of Development, Cell Therapy R&D, you will have the opportunity to:Lead and set direction for the CTRD development area. Hold overall accountability for effective high-quality cell therapy drug development, including non-clinical and clinical development ensuring an end-to-end perspective Drive organizational and team member development in accordance with CTRD strategy and business objectives. Build strong relationships with the Novo Nordisk’s global Development organization and the US based East Coast Hub Development organization. Provide guidance and direction to the Clinical Operations, Medical Writing, Clinical Safety, and Data Science functions within the NN Development Organization. Maintain key lead roles on all cell therapy projects, ensuring effective project governance, collaboration and strategic alignment. Play an active role in the management of the strategically important Cell Therapy R&D project portfolio with high business impact for Novo Nordisk Engage in creating synergy and knowledge sharing across the portfolio to ensure optimal portfolio management Represent Development as a key member of the Cell Therapy R&D Leadership Team, providing overviews on all cell therapy projects and contributing to the overall direction of the CTRD unit. The role is based in Målov, Denmark and involves working with a global team across several time zones (some of which are 9-hours apart). Travel requirement is estimated to be 30%.
Qualifications
You are an experienced executive within the global pharmaceutical industry. Recognized as an innovative enterprise leader, you possess:Over 10 years of leadership experience within a global pharmaceutical company and/or biotech A comprehensive understanding of global drug development and the R&D value chain (ideally from a variety of functions) Experience leading global drug development projects including strategic product development and interaction with key regulatory authorities, KOLs etc. Experience from several distinct therapy areas (ATMPs/cell therapy experience is preferred but not required) Experience building, motivating and leading high performing individuals and teams Experience leading and navigating in a large, international matrix organization An international mindset and experience either through an international assignment or extensive work with major markets and partners. Academic degree (PhD, MD or MD/PhD) As a person, you are a strong communicator and bridge builder with well-developed interpersonal skills and a flair for complex stakeholder management. You are an engaging and motivating leader, able to make clear decisions, set direction and empower your team. You are curious by nature and are passionate about innovation and exploring new areas with disruptive potential. You thrive in flexible, dynamic, and cross-functional collaborative environments. You function as a role model by being accountable, ambitious, engaged with stakeholders, open, honest and ready for change.
Deadline
14 July 2024. To ensure an efficient and fair recruitment process, please do not add a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
Contact Details
For further information, please contact Executive Search Partner, Heidi Ashby at [email protected]. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
In Cell Therapy R&D, our mission is to improve the lives of patients suffering from serious chronic diseases through innovative stem cell-based therapies. We want to be an industry leader in this rapidly developing area, which has the potential to address unmet medical needs and even cure serious chronic diseases. As a dedicated Transformational Research Unit (TRU) since late 2018, we have a high level of independence, agility and flexibility. This means we can combine the speed and agility of a small biotech with the capabilities of a major pharma company. We cover the full pharmaceutical value chain, from research to commercial, including a GMP manufacturing site in Fremont, working in close collaboration with leading international scientists and colleagues across Novo Nordisk. Novo Nordisk has been active in stem cell research for over 20 years in type 1 diabetes. Our portfolio has since expanded to many disease areas and indications, all working towards maturing and expanding our platform and capabilities.The Cell Therapy Development area is part of Cell Therapy R&D and encompasses an organization of approximately 22 professionals spread across several locations and time zones. Located at our Målov site in Denmark, the team collaborates closely with the larger Novo Nordisk Development organization, including the newly formed US-based “East Coast Hub” and our commercial partners in Rare Disease. The department is known for its collaborative and innovative approach to drug development, and we are committed to making a difference in the lives of patients.
The Position
Reporting to the Corporate Vice President for Cell Therapy R&D (CTRD), the new Vice President (VP) for Development will be a critical part of the CTRD leadership team, accountable for several functions involved in late-stage research and early to mid-stage clinical development of stem cell-based therapies. The new VP will have accountability for securing high quality, comprehensive drug development strategies for our cell therapy projects, covering all critical aspects incl. non-clinical, clinical development and maintaining strong collaborative efforts with internal and external partners.
As the Vice President of Development, Cell Therapy R&D, you will have the opportunity to:
Qualifications
You are an experienced executive within the global pharmaceutical industry. Recognized as an innovative enterprise leader, you possess:
Deadline
14 July 2024. To ensure an efficient and fair recruitment process, please do not add a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
Contact Details
For further information, please contact Executive Search Partner, Heidi Ashby at [email protected]. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Måløv.
Jobbet er oprettet på vores service den 21.6.2024, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Måløv
Lignende jobs
-
Strategic Trial Planning Manager - Clinical Develo...
Are you ready to drive the successful strategic planning and management of early phase clinical trials, i.e. ClinPharm/Phase 1 studies? Does oversight and cross functional collaboration motivate yo..- Forretningsudvikler
- Søborg
-
Senior Scientist in Late-stage Downstream Developm...
Are you ready to shape the future of API process characterization in late-stage downstream development? Do you have the expertise to drive innovative solutions and ensure seamless tech transfer in .- Forretningsudvikler
- Bagsværd
-
Global Trial Manager
Are you passionate about clinical development? Is ensuring that clinical trials produce high-quality data and scientific documentation your top priority? If so, we want you to join our team in Card..- Forretningsudvikler
- Søborg
-
Udviklingskonsulent til det sociale børne- og unge...
- Forretningsudvikler
- Taastrup
Statistik over udbudte jobs som forretningsudviklere i Måløv
Herunder ser du udviklingen i udbudte forretningsudvikler i Måløv over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Måløv over tid
Dato | Alle jobs som forretningsudviklere |
---|---|
22. november 2024 | 3 |
21. november 2024 | 3 |
20. november 2024 | 4 |
19. november 2024 | 3 |
18. november 2024 | 3 |
17. november 2024 | 5 |
16. november 2024 | 5 |
15. november 2024 | 5 |
14. november 2024 | 5 |
13. november 2024 | 5 |
12. november 2024 | 5 |
11. november 2024 | 4 |
10. november 2024 | 4 |
9. november 2024 | 4 |
8. november 2024 | 3 |
7. november 2024 | 2 |
6. november 2024 | 1 |
5. november 2024 | 1 |
4. november 2024 | 1 |
3. november 2024 | 3 |
2. november 2024 | 3 |
1. november 2024 | 3 |
31. oktober 2024 | 4 |
30. oktober 2024 | 4 |
29. oktober 2024 | 4 |
28. oktober 2024 | 4 |
27. oktober 2024 | 6 |
26. oktober 2024 | 6 |
25. oktober 2024 | 7 |
24. oktober 2024 | 7 |
23. oktober 2024 | 7 |